Stay updated on Nivolumab and Cyclophosphamide for R/R AML Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-03-25T19:58:41.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T05:11:28.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and Revision: v3.4.1 was removed in the page metadata. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-17T21:11:51.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added. The notices about government funding lapse and the previous Revision: v3.4.0 were removed.
    Difference
    0.4%
    Check dated 2026-02-09T14:54:54.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now shows a glossary and adds QC-related metadata labels ('Last Update Submitted that Met QC Criteria') along with a revision note ('Revision: v3.4.0'), while older QC label, no-FEAR Act data note, and the prior revision label ('v3.3.4') were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-26T09:42:36.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-19T07:29:09.000Z thumbnail image

Stay in the know with updates to Nivolumab and Cyclophosphamide for R/R AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page.